Search
Tuesday 9 June 2015
  • :
  • :
Latest Update

Volume Active Stocks in Queue- Brixmor Property Group (NYSE:BRX), FMSA Holdings (NYSE:FMSA), Lattice Semiconductor (NASDAQ:LSCC), Alexion Pharmaceuticals, (NASDAQ:ALXN)

On Monday, Brixmor Property Group Inc (NYSE:BRX)’s shares inclined 0.36% to $24.87.

Brixmor Property Group Inc (BRX) declared that its administration will present at the NAREIT REITWeek conference in New York, New York on Wednesday, June 10, 2015 from 2:45 PM ET to 3:15 PM ET.

Brixmor Property Group Inc. owns and operates various grocery-anchored community and neighborhood shopping centers in the United States. As of March 31, 2013, the company owned interests in 532 community and neighborhood shopping centers comprising 526 wholly owned community and neighborhood shopping centers; and 6 community and neighborhood shopping centers held through unmerged real estate joint ventures. Brixmor Property Group Inc. was formerly known as CENTRO SUPER RESIDUAL HOLDING 2 LLC.

FMSA Holdings Inc (NYSE:FMSA)’s shares gained 0.22% to $8.95.

FMSA Holdings Inc (FMSA) declared results for the first quarter ended March 31, 2015.

First Quarter 2015 Results vs. Prior Year

First quarter 2015 revenue totaled $301.5 million, up 2% from $294.9 million for the same period in 2014. Overall sales volumes raised to 2.3 million tons for the quarter, an 8% enhance contrast with 2.1 million tons in the first quarter of 2014. The enhance in volumes in the first quarter of 2015 over the prior year period was primarily due to continued strong demand resulting from raised proppant intensity and improved service levels driven by better weather conditions and improved rail service contrast with last year.

For the first quarter, net income was $30.8 million, or $0.18 per diluted share, contrast with net income of $34.5 million, or $0.21 per diluted share, for the same period a year ago. Adjusted earnings per diluted share were $0.19, contrast with adjusted earnings per diluted share of $0.21 for the first quarter of 2014. Adjusted EBITDA for the first quarter was $75.1 million, down 9% from first quarter 2014 Adjusted EBITDA of $82.1 million. Adjusted EBITDA was influenced by a decline in contribution margin in our Proppant Solutions segment and an enhance in year-over-year SG&A expenses driven mostly by costs associated with being a public company.

FMSA Holdings Inc., together with its auxiliaries, provides sand-based proppant solutions for exploration and production companies to enhance the productivity of their oil and gas wells. It operates in two segments, Proppant Solutions and Industrial & Recreational (I&R) Products.

At the end of Monday’s trade, Lattice Semiconductor (NASDAQ:LSCC)‘s shares surged 2.88% to $6.44.

SiBEAM, Inc., a Lattice Semiconductor company (LSCC), declared that Google ATAP has selected SiBEAM® as one of the partners to bring touchless gesture sensing to tomorrow’s smart devices. Based on SiBEAM’s millimeter-wave (mmWave) innovations, this technology enables rich hand gesture interactions with smart devices, without the limitations of ever-shrinking screen sizes.

At Google I/O in San Francisco recently, Google’s Advanced Technology and Projects (ATAP) group declared Project Soli. The aim of Project Soli is to create next-generation gesture technology that enables rich interactions with smart devices regardless of screen size to drive applications across wearable, home automation, automotive, industrial and medical markets. SiBEAM’s solution is ideal for Google ATAP given its ability to detect micro-gestures with minimal interference and in very small form factors. At the show, the first Project Soli proof of concept chip was declared, which is a joint technology development between SiBEAM and Google ATAP.

SiBEAM’s touchless gesture sensing technology is based on 3D phased array beamforming and mmWave wireless born out of UC Berkeley Labs. The company was also the first to market with wireless gigabit mobile video products.

Lattice Semiconductor Corporation designs, develops, and markets programmable logic products and related software in Asia, Europe, and the Americas. It offers products based on field programmable gate arrays (FPGAs) and complex programmable logic devices (CPLDs) architectures.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), ended its Monday’s trading session with 0.57% gain, and closed at $164.78.

Alexion Pharmaceuticals, Inc. (ALXN) and Synageva BioPharma Corp. (Nasdaq:GEVA) recently declared that the U.S. Federal Trade Commission (FTC) has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) with respect to Alexion’s pending acquisition of Synageva. The waiting period was planned to expire on June 15, 2015.

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *